Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS
暂无分享,去创建一个
Meilan K. Han | F. Martinez | D. Couper | G. Criner | S. Rennard | M. Scholand | N. Hansel | R. Barr | L. LaVange | L. Postow | J. Newell | J. Wells | M. Dransfield | N. Alexis | R. Kanner | W. O'Neal | J. Krishnan | S. Lazarus | P. Woodruff | L. Paulin | N. Putcha | A. Comellas | W. Labaki | R. Wise | R. Boucher | R. Kaner | Wells Jn | S. Christenson | D. Tashkin | V. Sidhaye | C. Freeman | E. Kleerup | Gabriel G Paul | C. Martinez | A. Lambert | K. Psoter | E. Oelsner | T. Croxton | A. Hastie | Elizabeth E. Carretta | R. Crystal | C. Doerschuk | R. Graham Barr | A. Fawzy | J. Curtis | R. Bowler | D. Meyers | J. Woo | C. Cooper | W. Anderson | W. O’Neal | F. Martinez | M. Han | E. Bleecker | R. Wise | E. Hoffman | Robert Paine | Nycomed GmbH
[1] N. Hansel,et al. Cigarette smoke disrupts monolayer integrity by altering epithelial cell-cell adhesion and cortical tension. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[2] David Couper,et al. SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. , 2016, American journal of respiratory and critical care medicine.
[3] M. Ferrari,et al. Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease , 2015, BMC Pulmonary Medicine.
[4] Courtney Crim,et al. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. , 2015, Annals of the American Thoracic Society.
[5] Jasmine Khatana,et al. Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact , 2015, Lung India : official organ of Indian Chest Society.
[6] R. Peng,et al. Obesity as a susceptibility factor to indoor particulate matter health effects in COPD , 2015, European Respiratory Journal.
[7] E. Regan,et al. A Simplified Score to Quantify Comorbidity in COPD , 2014, PloS one.
[8] Thierry Troosters,et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.
[9] Matthew C. Gibson,et al. Cell division and the maintenance of epithelial order , 2014, The Journal of cell biology.
[10] W. Timens,et al. A-kinase anchoring proteins contribute to loss of E-cadherin and bronchial epithelial barrier by cigarette smoke. , 2014, American journal of physiology. Cell physiology.
[11] Meilan K. Han,et al. Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study , 2014, Journal of Translational Medicine.
[12] R. Peng,et al. Indoor pollutant exposures modify the effect of airborne endotoxin on asthma in urban children. , 2013, American journal of respiratory and critical care medicine.
[13] E. Walters,et al. Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD) , 2013, Respiratory Research.
[14] Donavan T. Cheng,et al. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[15] Lisa M LaVange,et al. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.
[16] Patrick Royston,et al. Marginscontplot: Plotting the Marginal Effects of Continuous Predictors , 2013 .
[17] Helmy Haja Mydin,et al. Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease , 2013, International journal of chronic obstructive pulmonary disease.
[18] E. Walters,et al. Epithelial mesenchymal transition (EMT) in small airways of COPD patients , 2013, Thorax.
[19] Martijn A Spruit,et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[20] B. Celli,et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[21] R. Forteza,et al. Hyaluronan and Layilin Mediate Loss of Airway Epithelial Barrier Function Induced by Cigarette Smoke by Decreasing E-cadherin* , 2012, The Journal of Biological Chemistry.
[22] M. Polkey,et al. Anemia and Survival in Chronic Obstructive Pulmonary Disease: A Dichotomous rather than a Continuous Predictor , 2012, Respiration.
[23] J. Morera,et al. Anemia is a Mortality Predictor in Hospitalized Patients for COPD Exacerbation , 2012, COPD.
[24] J. Wedzicha,et al. The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. , 2012, Chest.
[25] G. G. Casasola,et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor , 2012, Current Medical Research and Opinion.
[26] I. Stanopoulos,et al. Anemia of Chronic Disease in Chronic Obstructive Pulmonary Disease: A Case-Control Study of Cardiopulmonary Exercise Responses , 2011, Respiration.
[27] Jiaquan Xu,et al. Deaths: preliminary data for 2009. , 2011, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[28] Josep Roca,et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes , 2010, Thorax.
[29] S. Johnsen,et al. Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation , 2010, Clinical epidemiology.
[30] P. Jones,et al. Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.
[31] P. J. Barnes,et al. Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.
[32] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[33] P. Jones,et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.
[34] Steve Selvin,et al. Statistical Analysis of Epidemiologic Data , 1991 .
[35] Beizer. Clinical significance of cardiac and respiratory adjustments in chronic anemia , 1948 .
[36] H. L. Blumgart,et al. Clinical significance of cardiac and respiratory adjustments in chronic anemia. , 1948, Blood.